ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Previous studies have shown that Scl/tTA-BCR::ABL1 mice exhibit clear CML characteristics within 4–8 weeks following doxycycline withdrawal, with a median survival rate of approximately 56 days [25].